Pfizer boosts obesity drug prospects with $7.3 billion deal to buy Metsera
Thomas Fuller | SOPA Images | Lightrocket | Getty ImagesPfizer on Monday said it would buy weight loss drugmaker Metsera ...
Tag: Novo Nordisk A/S
Eli Lilly to build $5 billion Virginia facility to boost production of targeted cancer drugs, other treatments
Eli Lilly Biotechnology Center is shown in San Diego, California, U.S. March 1, 2023. Mike Blake | ReutersEli Lilly on ...
Eli Lilly’s obesity pill remains a viable rival to Novo’s oral Wegovy despite data that underwhelmed investors
A sign with the company logo sits outside of the headquarters of Eli Lilly in Indianapolis, Indiana, on March 17, 2024.Scott ...
FDA approves first-ever glucose monitoring system for weight loss from Signos
Woman with Signos wearable and appSource: SignosThe Food and Drug Administration on Wednesday approved the first-ever glucose monitoring system specifically ...
Viking Therapeutics shares fall 40% on disappointing obesity pill trial data
Shares of Viking Therapeutics fell 40% on Tuesday after the company released mid-stage trial data on its obesity pill that ...
Trump says he asked 17 drugmakers to take steps to cut U.S. prices within 60 days
U.S. President Donald Trump, U.S. Health and Human Services (HHS) Secretary Robert F. Kennedy, Jr., Dr. Mehmet Oz, Administrator for ...
Weight loss drugs could be a gamechanger for women with a common hormonal disorder
Wegovy injection pens arranged in Waterbury, Vermont, US, on Monday, April 28, 2025.Shelby Knowles | Bloomberg | Getty ImagesFor well ...
Cigna announces new deal for copay caps on Eli Lilly and Novo Nordisk weight loss drugs
Wegovy injection pens arranged in Waterbury, Vermont, US, on Monday, April 28, 2025. Shelby Knowles | Bloomberg | Getty ImagesOnly ...
Novo Nordisk opens weight loss drug Wegovy to telehealth; Hims & Hers shares rocket 18%
The "Wegovy" brand slimming syringe is sold in the Achat pharmacy in Mitte. The "Wegovy" slimming syringe has been available ...
Novo Nordisk’s diabetes pill slashes risk of cardiovascular complications by 14% after four years
Novo Nordisk on Saturday said its diabetes pill Rybelsus showed cardiovascular benefits in a late-stage trial, paving the way for ...
